The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications

被引:182
|
作者
Ravera, Silvia [1 ]
Reyna-Neyra, Andrea [1 ]
Ferrandino, Giuseppe [1 ]
Amzel, L. Mario [2 ]
Carrasco, Nancy [1 ]
机构
[1] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA
[2] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA
来源
ANNUAL REVIEW OF PHYSIOLOGY, VOL 79 | 2017年 / 79卷
关键词
sodium/iodide symporter; thyroid hormones; NIS mutations; structure/function; gene transfer studies; imaging and radioiodide therapy; SODIUM-IODIDE SYMPORTER; ONCOLYTIC VACCINIA VIRUS; THYROID NA+/I-SYMPORTER; ADENOVIRUS-MEDIATED EXPRESSION; EPIDERMAL-GROWTH-FACTOR; PENDRED-SYNDROME GENE; BREAST-CANCER; IN-VIVO; TRANSPORT-DEFECT; MEASLES-VIRUS;
D O I
10.1146/annurev-physiol-022516-034125
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Active iodide (I-) transport in both the thyroid and some extrathyroidal tissues is mediated by the Na+/I- symporter (NIS). In the thyroid, NIS-mediated I- uptake plays a pivotal role in thyroid hormone (TH) biosynthesis. THs are key during embryonic and postembryonic development and critical for cell metabolism at all stages of life. The molecular characterization of NIS in 1996 and the use of radioactive I- isotopes have led to significant advances in the diagnosis and treatment of thyroid cancer and provide the molecular basis for studies aimed at extending the use of radioiodide treatment in extrathyroidal malignancies. This review focuses on the most recent findings on I- homeostasis and I- transport deficiency-causing NIS mutations, as well as current knowledge of the structure/function properties of NIS and NIS regulatory mechanisms. We also discuss employing NIS as a reporter gene using viral vectors and stem cells in imaging, diagnostic, and therapeutic procedures.
引用
收藏
页码:261 / 289
页数:29
相关论文
共 50 条
  • [31] Characterization of Thr-354 in the human sodium/iodide symporter (NIS) by site-directed mutagenesis
    Tatsumi, Ke-ita
    Fujiwara, Hirokazu
    Tanaka, Susumu
    Amino, Nobuyuki
    ENDOCRINE JOURNAL, 2010, 57 (11) : 997 - 999
  • [32] A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer
    Smith, Vicki E.
    Read, Martin L.
    Turnell, Andrew S.
    Watkins, Rachel J.
    Watkinson, John C.
    Lewy, Greg D.
    Fong, Jim C. W.
    James, Sally R.
    Eggo, Margaret C.
    Boelaert, Kristien
    Franklyn, Jayne A.
    McCabe, Christopher J.
    JOURNAL OF CELL SCIENCE, 2009, 122 (18) : 3393 - 3402
  • [33] The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery
    Hingorani, M.
    Spitzweg, C.
    Vassaux, G.
    Newbold, K.
    Melcher, A.
    Pandha, H.
    Vile, R.
    Harrington, K.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (02) : 242 - 267
  • [34] Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS)
    Hallinger, Daniel R.
    Murr, Ashley S.
    Buckalew, Angela R.
    Simmons, Steven O.
    Stoker, Tammy E.
    Laws, Susan C.
    TOXICOLOGY IN VITRO, 2017, 40 : 66 - 78
  • [35] Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene
    Schmohl, Kathrin A.
    Gupta, Aayush
    Gruenwald, Geoffrey K.
    Trajkovic-Arsic, Marija
    Klutz, Kathrin
    Braren, Rickmer
    Schwaiger, Markus
    Nelson, Peter J.
    Ogris, Manfred
    Wagner, Ernst
    Siveke, Jens T.
    Spitzweg, Christine
    ONCOTARGET, 2017, 8 (20) : 33393 - 33404
  • [36] A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer
    M A Trujillo
    M J Oneal
    S McDonough
    R Qin
    J C Morris
    Gene Therapy, 2010, 17 : 1325 - 1332
  • [37] The sodium iodide symporter: role in pathophysiology, diagnostics and therapy
    Spitzweg, C
    INTERNIST, 2003, 44 (04): : 396 - +
  • [38] Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS
    Oh, Ji Min
    Ahn, Byeong-Cheol
    THERANOSTICS, 2021, 11 (13): : 6251 - 6277
  • [39] Inter-species variation in monovalent anion substrate selectivity and inhibitor sensitivity in the sodium iodide symporter (NIS)
    Concilio, Susanna C.
    Zhekova, Hristina R.
    Noskov, Sergei Y.
    Russell, Stephen J.
    PLOS ONE, 2020, 15 (02):
  • [40] Development of a sodium/iodide symporter (NIS)-transgenic mouse for imaging of cardiomyocyte-specific reporter gene expression
    Kang, JH
    Lee, DS
    Paeng, JC
    Lee, JS
    Kim, YH
    Lee, YJ
    Hwang, DW
    Jeong, JM
    Lim, SM
    Chung, JK
    Lee, MC
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (03) : 479 - 483